Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 4,400.00

From 52W high−60.64%

Volume217835.00

Market capKRW 100.70B

P/E (TTM)—

P/S (TTM)15.5x

Div yield—

Key dataSep 18, 2026

Open

KRW 4,400.00

From 52W high

−60.64%

Volume

217835.00

Market cap

KRW 100.70B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.5x

P/E (TTM)

—

RSI (14)

48.5

MomentumView details →

1D Return

−0.80%

YTD Return

−56.86%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−6.5x

EV/Sales

13.4x

P/S (TTM)

15.5x

P/B (TTM)

1.9x

ProfitabilityView details →

Gross Margin

−18.75%

Net Margin

−229.11%

EBITDA Margin

−207.75%

ROE (TTM)

−28.00%

ROA (TTM)

−25.42%

Asset Turnover

0.11x

GrowthView details →

Revenue YoY

+17.35%

EPS YoY

−21.22%

FCF YoY

−72.46%

Revenue CAGR 3Y

+2167.56%

EPS CAGR 3Y

−24.71%

EBITDA YoY

—

MomentumView details →

1D Return

−0.80%

YTD Return

−56.86%

1Y Return

−53.41%

RSI (14)

48.5

vs 50D SMA

+2.63%

vs 200D SMA

−38.85%

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

5.56x

Quick Ratio

5.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

6.51B

Net Income (TTM)

−14.92B

Op. CF (TTM)

−10.61B

Latest newsMore news →

No recent news for 323990.KQ.

Similar companies

iNtRON Biotechnology, Inc.048530.KQ MedPacto, Inc.235980.KQ Sino Biopharmaceutical Limited01177.HK CG Invites Co., Ltd.083790.KQ Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK ORIENT BIO Inc.002630.KS Find similar companies →

Latest newsMore news →

No recent news for 323990.KQ.